Wells Fargo Portfolio holdings
Wells Fargo & Company, founded in 1852 by Henry Wells and William Fargo, is a major American financial institution headquartered in San Francisco, California, known for its extensive retail banking network and historical roots in the American West. Offering a wide range of services—including consumer banking, mortgages, wealth management, and commercial finance—it manages trillions in assets and serves millions of customers through thousands of branches and ATMs across the U.S. Despite its prominence, Wells Fargo faced significant scrutiny following a 2016 scandal involving millions of unauthorized accounts, leading to leadership changes and regulatory penalties, though it has since focused on rebuilding trust and enhancing digital banking capabilities. With a legacy tied to stagecoaches and a modern focus on diversified financial services, Wells Fargo remains a key player in the U.S. banking sector.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$927M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$430M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$382M |
| 5 |
Goldman Sachs ActiveBeta International Equity ETF
GSIE
|
+$306M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.03B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$507M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$430M |
| 4 |
iShares Russell Mid-Cap ETF
IWR
|
+$356M |
| 5 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.75% |
| 2 | Healthcare | 8.81% |
| 3 | Financials | 8.45% |
| 4 | Consumer Discretionary | 7.56% |
| 5 | Industrials | 7.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
BridgeBio Pharma
BBIO
$16.5B
| $3.2M | ﹤0.01% |
68,196
+31,585
| +86% | +$1.69M |
|
3152
PUT
Delta Air Lines
DAL
$60.1B
| $3.2M | ﹤0.01% |
75,000
-80,000
| -52% | -$3.27M |
|
3153
Community Health Systems
CYH
$423M
| $3.19M | ﹤0.01% |
272,821
+9,403
| +4% | +$123K |
|
3154
Alpha and Omega Semiconductor
AOSL
$1.08B
| $3.19M | ﹤0.01% |
101,554
+22,549
| +29% | +$625K |
|
|
SMED
3155
DELISTED
Sharps Compliance Corp
SMED
| $3.18M | ﹤0.01% |
385,014
+50,057
| +15% | +$466K |
|
3156
Ceco Environmental
CECO
$4.14B
| $3.18M | ﹤0.01% |
451,733
+43,053
| +11% | +$306K |
|
3157
Park National Corp
PRK
$3.67B
| $3.18M | ﹤0.01% |
26,070
+1,171
| +5% | +$136K |
|
3158
iShares Morningstar Multi-Asset Income ETF
IYLD
$126M
| $3.18M | ﹤0.01% |
132,624
-9,903
| -7% | -$240K |
|
3159
Urban Edge Properties
UE
$2.73B
| $3.17M | ﹤0.01% |
173,040
-13,372
| -7% | -$249K |
|
|
LOGC
3160
DELISTED
ContextLogic
LOGC
| $3.16M | ﹤0.01% |
19,305
+14,687
| +318% | +$3.66M |
|
3161
Scholastic
SCHL
$792M
| $3.16M | ﹤0.01% |
88,544
-2,876
| -3% | -$98.3K |
|
3162
Rush Enterprises Class A
RUSHA
$6.22B
| $3.15M | ﹤0.01% |
104,717
-16,302
| -13% | -$482K |
|
3163
Harmony Biosciences
HRMY
$2.24B
| $3.15M | ﹤0.01% |
82,144
+72,383
| +742% | +$2.33M |
|
3164
Nuveen Core Equity Alpha Fund
JCE
$288M
| $3.14M | ﹤0.01% |
183,521
+16,304
| +10% | +$276K |
|
3165
TG Therapeutics
TGTX
$7.62B
| $3.14M | ﹤0.01% |
94,202
+26,294
| +39% | +$813K |
|
3166
State Street Income Allocation ETF
INKM
$75.4M
| $3.13M | ﹤0.01% |
89,178
-45,601
| -34% | -$1.63M |
|
|
IRBT
3167
DELISTED
iRobot
IRBT
| $3.13M | ﹤0.01% |
39,878
-21,661
| -35% | -$1.85M |
|
|
OCDX
3168
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
| $3.13M | ﹤0.01% |
169,331
-1,312,151
| -89% | -$26.4M |
|
|
TBI
3169
Trueblue
TBI
$311M
| $3.13M | ﹤0.01% |
115,490
+20,815
| +22% | +$557K |
|
|
ITIC
3170
Investors Title Co
ITIC
$547M
| $3.12M | ﹤0.01% |
17,104
-896
| -5% | -$161K |
|
3171
Invesco BulletShares 2026 High Yield Corporate Bond ETF
BSJQ
$867M
| $3.12M | ﹤0.01% |
121,437
+4,924
| +4% | +$127K |
|
3172
Rambus
RMBS
$11B
| $3.12M | ﹤0.01% |
140,474
-22,181
| -14% | -$522K |
|
|
DMB
3173
BNY Mellon Municipal Bond Infrastructure Fund
DMB
$196M
| $3.11M | ﹤0.01% |
199,551
+13,808
| +7% | +$213K |
|
3174
iShares MSCI Netherlands ETF
EWN
$713M
| $3.11M | ﹤0.01% |
63,072
+10,754
| +21% | +$546K |
|
|
SFIX
3175
Stitch Fix
SFIX
$560M
| $3.1M | ﹤0.01% |
77,571
+4,399
| +6% | +$206K |
|
Similar funds
Wells Fargo's Q3 2021 Portfolio in Review
As of Q3 2021, Wells Fargo held 8,005 positions worth $455B, down 0.26% from $456B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Wells Fargo's Q3 2021 filing shows 478 new, 3,039 increased, 3,074 reduced and 321 closed positions. Its largest new stake was Blend Labs: 6,286,123 shares worth $84.7M. The largest sale was iShares Russell 2000 ETF, an estimated $1.03B.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
- Wells Fargo's largest Q3 2021 buy was Blend Labs: 6,286,123 shares worth $84.7M.
- Wells Fargo added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $1.04B increase.
- Wells Fargo's biggest Q3 2021 reduction was iShares Russell 2000 ETF, cutting an estimated $1.03B.
- Wells Fargo fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $166M.
- Wells Fargo's ten largest holdings make up 16% of its $455B portfolio in Q3 2021.
- Wells Fargo opened 478 new positions and closed 321 in Q3 2021.
- Wells Fargo's portfolio value fell 0.26% quarter-over-quarter to $455B.
Based on Wells Fargo's 13F filing for Q3 2021, filed 15 Nov 2021.